APOTHEEK COLLA-ACKX
0434.122.906 · rovalta.com · 24/09/2026
APOTHEEK COLLA-ACKX
Overview
What does APOTHEEK COLLA-ACKX do?
APOTHEEK COLLA-ACKX is a Public limited company incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Diepenbeek.
3590 Diepenbeek · FlandreSee on map
Joint committees (2)
- 313
- 3130
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 330,5 k € | -8.5% | 361,1 k € | +10.1% | 328 k € | +2.4% | 320,4 k € | +16.5% | 274,9 k € | -8.5% | 300,6 k € | -4.0% | 313 k € | +0.5% | 311,2 k € | +9.2% | 284,9 k € | +5.2% | 270,7 k € | +13.0% | 239,5 k € | +4.7% | 228,8 k € | +1.2% | 226 k € | +27.9% | 176,8 k € | -8.0% | 192,1 k € | -1.7% | 195,4 k € | +15.5% | 169,1 k € | +1.3% | 167 k € | +13.2% | 147,5 k € | +21.7% | 121,2 k € |
| EBITDA | 253 k € | -5.1% | 266,7 k € | +42.5% | 187,2 k € | -0.3% | 187,8 k € | +44.1% | 130,3 k € | -18.7% | 160,3 k € | +2.2% | 156,8 k € | -9.4% | 173,1 k € | +9.7% | 157,7 k € | +19.0% | 132,6 k € | +18.0% | 112,3 k € | +17.6% | 95,5 k € | +6.7% | 89,5 k € | +99.5% | 44,8 k € | -29.6% | 63,7 k € | -9.3% | 70,2 k € | +66.8% | 42,1 k € | -47.3% | 79,9 k € | -11.9% | 90,7 k € | +65.3% | 54,9 k € |
| Operating result | 224,6 k € | -11.5% | 253,7 k € | +44.6% | 175,4 k € | -0.2% | 175,8 k € | +52.8% | 115,1 k € | -24.4% | 152,3 k € | +8.4% | 140,4 k € | -8.6% | 153,7 k € | +9.7% | 140,1 k € | +16.1% | 120,7 k € | +20.7% | 100 k € | +20.6% | 82,9 k € | +4.8% | 79,1 k € | +131% | 34,3 k € | -31.8% | 50,3 k € | +4.2% | 48,2 k € | +142% | 20 k € | -69.2% | 64,8 k € | -15.2% | 76,4 k € | +85.6% | 41,2 k € |
| Net result | 190,6 k € | -15.8% | 226,2 k € | +31.7% | 171,7 k € | -0.9% | 173,3 k € | +33.2% | 130,2 k € | -26.5% | 177,1 k € | +11.0% | 159,5 k € | -8.3% | 173,9 k € | +9.3% | 159,1 k € | +12.1% | 141,9 k € | +11.1% | 127,7 k € | +14.3% | 111,8 k € | +7.0% | 104,5 k € | +54.1% | 67,8 k € | -12.6% | 77,6 k € | -3.1% | 80,1 k € | +43.6% | 55,8 k € | -41.5% | 95,4 k € | -11.0% | 107,2 k € | +59.7% | 67,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 257,2 k € | 0.0% | 257,2 k € | 0.0% | 257,2 k € | +0.3% | 256,5 k € | +0.1% | 256,2 k € | +0.1% | 256 k € | +0.0% | 255,9 k € | +0.2% | 255,5 k € | +0.0% | 255,4 k € | +0.0% | 255,3 k € | +0.4% | 254,4 k € | +0.7% | 252,6 k € | +1.1% | 249,9 k € | +0.6% | 248,4 k € | +3.2% | 240,6 k € | +3.3% | 233 k € | +4.5% | 222,9 k € | +2.7% | 217,2 k € | +5.0% | 206,8 k € | +3.6% | 199,6 k € |
| Total assets | 1,2 M € | +32.3% | 904,1 k € | +20.5% | 750,4 k € | +0.0% | 750,2 k € | +4.6% | 717,2 k € | +14.6% | 626 k € | -15.0% | 736,6 k € | +14.1% | 645,7 k € | -0.0% | 645,7 k € | +19.7% | 539,5 k € | +1.5% | 531,7 k € | +1.6% | 523,3 k € | +7.7% | 485,8 k € | +3.9% | 467,3 k € | +10.0% | 425 k € | +1.2% | 420,1 k € | -11.0% | 472,1 k € | -4.8% | 496,2 k € | +6.3% | 466,9 k € | -0.4% | 468,9 k € |
| Cash | 287,1 k € | -37.1% | 456,8 k € | +81.5% | 251,7 k € | -7.4% | 271,7 k € | +14.8% | 236,7 k € | +107% | 114,2 k € | -51.2% | 234,2 k € | +39.0% | 168,5 k € | -2.5% | 172,9 k € | -8.1% | 188,2 k € | -9.5% | 207,9 k € | +13.8% | 182,6 k € | +54.6% | 118,1 k € | -5.1% | 124,5 k € | -5.0% | 131,1 k € | +19.8% | 109,4 k € | -19.1% | 135,2 k € | +6.5% | 127 k € | +10.6% | 114,8 k € | -10.2% | 127,9 k € |
| Debts | 933,3 k € | +45.1% | 643 k € | +31.7% | 488,1 k € | -0.8% | 491,9 k € | +7.6% | 456,9 k € | +24.2% | 367,8 k € | -22.7% | 475,7 k € | +23.7% | 384,6 k € | -0.9% | 388,3 k € | +38.6% | 280,2 k € | +1.8% | 275,3 k € | +2.5% | 268,6 k € | +16.3% | 230,9 k € | +11.9% | 206,4 k € | +13.1% | 182,5 k € | -1.8% | 185,9 k € | -24.4% | 245,9 k € | -11.3% | 277,4 k € | +7.2% | 258,8 k € | -3.5% | 268 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 0,0 ETP | 0,0 ETP | -100% | 2,6 ETP | -3.7% | 2,7 ETP | +3.8% | 2,6 ETP | 0.0% | 2,6 ETP | -16.1% | 3,1 ETP | +34.8% | 2,3 ETP | 0.0% | 2,3 ETP | -14.8% | 2,7 ETP | +170% | 1,0 ETP | -64.3% | 2,8 ETP | 0.0% | 2,8 ETP | 0.0% | 2,8 ETP | 0.0% | 2,8 ETP | 0.0% | 2,8 ETP | -6.7% | 3,0 ETP | +30.4% | 2,3 ETP | +21.1% | 1,9 ETP | +5.6% | 1,8 ETP | |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 7 ended
Other companies at this address
| Company | CBE no. |
|---|---|
AXCOFARMA● Active | 0889.949.363 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/07/2026 | 07/07/2025 | 19/07/2024 | 27/06/2023 | 14/07/2022 | 25/06/2021 |
| General meeting | 25/04/2026 | 17/05/2025 | 27/04/2024 | 29/04/2023 | 30/04/2022 | 22/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 25/04/2026 | 15/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 17/05/2025 | 07/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 27/04/2024 | 19/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 29/04/2023 | 27/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/04/2022 | 14/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 22/05/2021 | 25/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/05/2020 | 15/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 27/04/2019 | 28/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 28/04/2018 | 27/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 29/04/2017 | 30/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/04/2016 | 04/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 25/04/2015 | 27/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 22/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 30/06/2013 | 29/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/06/2012 | 14/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 04/06/2011 | 25/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 15/05/2010 | 10/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 16/05/2009 | 11/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 17/05/2008 | 12/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 09/06/2007 | 05/07/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 7 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025190,6 k €↓
- 2024Annual accounts 2024226,2 k €↑
- 2023Annual accounts 2023171,7 k €↓
- 2023Name changeApotheek Colla-Ackx
- 2022Annual accounts 2022173,3 k €↑
- 2021Annual accounts 2021130,2 k €↓
- 2020Annual accounts 2020177,1 k €↑
- 2019Annual accounts 2019159,5 k €↓
- 2018Annual accounts 2018173,9 k €↑
- 2017Annual accounts 2017159,1 k €↑
- 2016Annual accounts 2016141,9 k €↑
- 2015Annual accounts 2015127,7 k €↑
- 2014Annual accounts 2014111,8 k €↑
- 2013Annual accounts 2013104,5 k €↑
- 2012Annual accounts 201267,8 k €↓
- 2011Annual accounts 201177,6 k €↓
- 2010Annual accounts 201080,1 k €↑
- 2009Annual accounts 200955,8 k €↓
- 2008Annual accounts 200895,4 k €↓
- 2007Annual accounts 2007107,2 k €↑
- 2006Annual accounts 200667,1 k €
- 2006Name changeApoteek Colla-Ackx
- 22/04/1988IncorporationPublic limited company